3 articles
The two-month-old startup founded by Shanda billionaire Tianqiao Chen and former NeuroXess founder Phoenix Peng secures the largest early-stage BCI funding in China, betting that focused ultrasound can reach deeper brain circuits than any implant.
A Chinese company is developing non-invasive ultrasound brain-computer interfaces to treat chronic pain, intensifying competition in alternatives to surgical neural implants.
Researchers demonstrate that individualized fMRI models can decode spontaneous pain in chronic pain patients, marking a shift toward objective, brain-based pain measurement that could reshape treatment and neurotech interventions.
Get the latest BCI news, breakthroughs, and market moves delivered to your inbox.
No spam. One-click unsubscribe. We respect your privacy.